Esperion Therapeutics Inc. (ESPR)
NASDAQ · Healthcare
Esperion Therapeutics Inc. Cash on Hand 2018–2025
Esperion Therapeutics Inc. annual cash on hand history from 2018 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Esperion Therapeutics Inc. cash on hand as of December 31, 2025: 167.9M, a 15.95% increase year-over-year.
- Esperion Therapeutics Inc. cash on hand for 2025 were 167.9M, a 15.95% increase from 2024.
- Esperion Therapeutics Inc. cash on hand for 2024 were 144.8M, a 76.01% increase from 2023.
- Esperion Therapeutics Inc. cash on hand for 2023 were 82.2M, a 34.08% decrease from 2022.
- Esperion Therapeutics Inc. cash on hand for 2022 were 124.8M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Esperion Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $168 |
| 2024 | $145 |
| 2023 | $82 |
| 2022 | $125 |
| 2021 | $209 |
| 2020 | $305 |
| 2019 | $166 |
| 2018 | $37 |
Esperion Therapeutics Inc. Cash on Hand — FAQ
Esperion Therapeutics Inc. (ESPR) cash on hand over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ESPR's cash on hand history?
The chart and table above show Esperion Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.